2012 (English)Patent (Other (popular science, discussion, etc.))
Abstract: The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in such profiles in a subject which are caused by or correlated with the said diseases or disorders. Such disturbances can be normalised by treatment of the subject with specified compounds, particularly N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine or an aminoguanidine.
Place, publisher, year, edition, pages
IdentifiersURN: urn:nbn:se:umu:diva-88201OAI: oai:DiVA.org:umu-88201DiVA: diva2:714281